Skip to main
ADUS

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 13%
Sell 13%
Strong Sell 0%

Bulls say

Addus HomeCare Corp has demonstrated impressive organic revenue growth, achieving +12.3% year-over-year in 2023, followed by +7.7% in 2024 and +7.4% year-to-date in 2025, indicating resilience and effective management in its personal care segment. The recent 2.6% Medicare Hospice rate increase set to take effect in 2025 is expected to further enhance revenue streams, particularly in the key hospice segment, which is transitioning to a stable growth state. Additionally, anticipated mergers and acquisitions, along with local operational enhancements, position the company favorably for continued revenue expansion in the near term.

Bears say

Addus HomeCare has faced significant challenges in 2025, notably experiencing same-store declines driven primarily by the ongoing impacts of Medicaid redeterminations, which have created administrative bottlenecks that hinder patient onboarding and lead to higher discharge rates compared to new admissions. Around 97% of its segment revenues are tied to Medicaid, generating considerable uncertainty regarding future funding due to legislative changes like the One Big Beautiful Bill Act (OBBBA), which potentially jeopardizes revenue stability. Despite some positive short-term operational execution, the stock's performance has lagged behind competitors in the post-acute care sector, indicating a disconnect between equity valuation and the underlying financial health and growth trajectory of the company.

Addus HomeCare (ADUS) has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 13% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 8 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $135.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $135.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.